We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

News · July 27, 2020

ASRS 2020: Endolaserless Vitrectomy With Aflibercept Monotherapy Leads to Significant Visual Gains in PDR-Related Vitreous Hemorrhage

Persistent, frequent postoperative anti-VEGF therapy is needed to optimize outcomes and reduce complications.

PracticeUpdate Editorial Team


Further Reading